LDHC and breast carcinoma: In order to investigate the role of LDHC in breast cancer, its expression was stably silenced in three basal‐like breast cancer cell lines (MDA‐MB‐468, BT‐549, MDA‐MB‐231) alongside one nonbasal, luminal A breast cancer cell line (HCC‐1500).